These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38559427)

  • 1. Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review.
    Mario A; Ivana L; Anita M; Silvio M; Claudia A; Mariaclaudia M; Antonello B
    Clin Neuropsychiatry; 2024 Feb; 21(1):32-62. PubMed ID: 38559427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mediators of cognitive impairment in bipolar disorder.
    Bauer IE; Pascoe MC; Wollenhaupt-Aguiar B; Kapczinski F; Soares JC
    J Psychiatr Res; 2014 Sep; 56():18-27. PubMed ID: 24862657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.
    Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS
    J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
    Misiak B; Stańczykiewicz B; Kotowicz K; Rybakowski JK; Samochowiec J; Frydecka D
    Schizophr Res; 2018 Feb; 192():16-29. PubMed ID: 28416092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review.
    Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T
    Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cognitive impairments with lipid profiles and inflammatory biomarkers in unipolar and bipolar depression.
    Zhang SF; Chen HM; Xiong JN; Liu J; Xiong J; Xie JZ; Wang XM; Tian Q; Xia B; Li Y; Qu N
    J Psychiatr Res; 2022 Jun; 150():300-306. PubMed ID: 35429740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Transcranial Magnetic Stimulation on Cognitive Functioning in Bipolar Depression: A Systematic Review.
    Strelnik A; Strelnik S; Markina E; Zakharov A; Kolsanov A; Smirnova D
    Psychiatr Danub; 2022 Sep; 34(Suppl 8):179-188. PubMed ID: 36170725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between multimodal neuroimaging and peripheral inflammation in different subtypes and mood states of bipolar disorder: a systematic review.
    Long JY; Li B; Ding P; Mei H; Li Y
    Int J Bipolar Disord; 2024 Feb; 12(1):5. PubMed ID: 38388844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the biomarkers associated with cognition and mood state in bipolar disorder.
    Pérez-Ramos A; Romero-López-Alberca C; Hidalgo-Figueroa M; Berrocoso E; Pérez-Revuelta JI
    Int J Bipolar Disord; 2024 May; 12(1):18. PubMed ID: 38758506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.
    Rowland T; Perry BI; Upthegrove R; Barnes N; Chatterjee J; Gallacher D; Marwaha S
    Br J Psychiatry; 2018 Sep; 213(3):514-525. PubMed ID: 30113291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
    Karthikeyan S; Dimick MK; Fiksenbaum L; Jeong H; Birmaher B; Kennedy JL; Lanctôt K; Levitt AJ; Miller GE; Schaffer A; Young LT; Youngstrom EA; Andreazza AC; Goldstein BI
    Brain Behav Immun; 2022 Feb; 100():278-286. PubMed ID: 34896179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
    Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
    Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional MRI correlates of inflammation in bipolar disorder: A systematic review.
    Saccaro LF; Crokaert J; Perroud N; Piguet C
    J Affect Disord; 2023 Mar; 325():83-92. PubMed ID: 36621677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value of Inflammatory and Neurotrophic Biomarkers in Bipolar Disorder: A Systematic Review and Meta-Analysis.
    Vega-Núñez A; Gómez-Sánchez-Lafuente C; Mayoral-Cleries F; Bordallo A; Rodríguez de Fonseca F; Suárez J; Guzmán-Parra J
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
    Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
    J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurococognitive and neuroimaging correlates of obesity and components of metabolic syndrome in bipolar disorder: a systematic review.
    Bora E; McIntyre RS; Ozerdem A
    Psychol Med; 2019 Apr; 49(5):738-749. PubMed ID: 30326979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
    Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.